(4+3) Cycloaddition Methodology Using Oxidopyridinium Ions for Seven-Membered Ring Synthesis
Synthetic methodology leveraging (4+3) cycloaddition reactions between dienes and oxidopyridinium ions to construct seven-membered carbocyclic and heterocyclic scaffolds. This approach offers a streamlined route to complex ring systems valuable in medicinal chemistry and natural product synthesis.
Overview
This offering centers on a synthetic methodology that employs (4+3) cycloaddition reactions between a range of dienes and oxidopyridinium ions to produce seven-membered ring structures. Seven-membered rings are a recurring motif in bioactive molecules and natural products, yet they remain comparatively difficult to access through conventional annulation strategies. The (4+3) cycloaddition with oxidopyridinium ions provides a direct, atom-economical route to these frameworks, expanding the toolbox available to medicinal chemists and process chemists who need efficient routes to medium-sized rings.
Technical specifications
- Reaction type: Formal (4+3) cycloaddition between dienes and oxidopyridinium ion intermediates
- Substrate scope: Compatible with various diene partners, enabling diversification of the resulting seven-membered scaffolds
- Design principle: Guided by the design rationale established in published work from the Harmata group
- Bond-forming strategy: Constructs seven-membered carbocycles and heterocycles in a single cycloaddition step, reducing the need for multi-step ring closures
- Applications: Useful building blocks for medicinal chemistry programs, natural product synthesis, and the preparation of medium-ring-containing intermediates
Technology readiness level
The methodology has been validated experimentally, with the hypothesis confirmed by successful reaction outcomes. Further validation studies are planned to broaden substrate scope and define reaction limitations. The approach is positioned as a research-stage synthetic method ready for collaborative refinement, scale-up studies, and application in target-oriented synthesis programs.
About University of Missouri, Columbia
Founded as Missouri’s flagship land‑grant, the University of Missouri–Columbia is a comprehensive public research university serving a large student body and partners statewide. Industry engages on campus through co‑located research cores, a research park and incubator in Columbia, and access to a high‑power university research reactor supporting isotope production and advanced testing. An integrated academic health system enables clinical studies and translation, while a statewide extension and agricultural research network links companies to field sites, producers, and community testbeds across Missouri. Research is supported by competitive federal funding from agencies such as NIH, NSF, USDA, and DOE. A dedicated tech transfer office supports IP, licensing, and sponsored‑research agreements.
delivered to your inbox.